MindMed’s LSD-Based Treatment Shows Promise for Anxiety Disorders
The field of psychedelics-based drug development has been promising for mental health treatments, but it hasn’t yet delivered significant breakthroughs. […]
The field of psychedelics-based drug development has been promising for mental health treatments, but it hasn’t yet delivered significant breakthroughs. […]
Hi there, I’m Abigail Beaney. I’m the editor of Clinical Trials Arena, a place where we talk about all things
The European Commission has shared its plans to boost the use of artificial intelligence (AI) in science and healthcare across
Turbine and AstraZeneca have joined forces to make better cancer treatments using special medicines called antibody-drug conjugates (ADCs). Turbine has
AC Immune SA has shared exciting news from their tests of two new treatments for early Alzheimer’s disease. These treatments,
Eli Lilly and top Alzheimer’s disease experts are asking for more investment in tools and resources to diagnose Alzheimer’s across
Today, we have some important news from Medicare, the Food and Drug Administration (FDA), and updates from several biotech companies
A large drug company, Bristol Myers Squibb (BMS), has decided to buy a smaller company called Orbital Therapeutics for $1.5
We’re pleased to welcome Annabel Kartal-Allen to our team. She writes for our health and medicine news sites. Annabel is
Takeda, a big Japanese drug company, has decided to stop its research on cell therapy. This is a type of